Replies to post #51785 on Ayala Pharmaceuticals Inc (ADXS)

[jckrdu]

Agree. It's always been about their cash position. Until that's resolved, we'll likely stay in the current trading range... $2.75 - $3.25, IMO.

No significant buyers with the cash concerns.
No significant sellers as there is expectation of imminent EU submission with potential partnership announcement.

Net result is we're stuck where we are. I think we see some significant news before proxies are mailed 2/9. I don't think the BOD sends those proxies (loaded guns) without something tangible announced beforehand. The BOD picked the date of the annual meeting and hence picked the 2/9 proxy mailing date for a reason, IMO.

GL all.